Are antidepressants useful in the treatment of minor depression: A critical update of the current literature

Current Opinion in Psychiatry

Volumn 25, Issue 1, 2012, Pages 1-6

  Hegerl, Ulrich ^a   Schönknecht, Peter ^a   Mergl, Roland ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

antidepressants; clinical trial; minor depression

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; HYPERICUM PERFORATUM EXTRACT; ILLICIUM VERUM EXTRACT; ISOCARBOXAZID; PAROXETINE; PLACEBO; PLANT EXTRACT; SERTRALINE; UNCLASSIFIED DRUG;

AFFECTIVE PSYCHOSIS; CLINICAL TRIAL (TOPIC); COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; FAMILY HISTORY; GASTROINTESTINAL SYMPTOM; GROUP THERAPY; HAMILTON SCALE; HUMAN; ILLICIUM VERUM; MAJOR DEPRESSION; META ANALYSIS; MINOR DEPRESSION; PATIENT MONITORING; PHARMACODYNAMICS; PRACTICE GUIDELINE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SELF HELP; SUICIDE; SUICIDE ATTEMPT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS; DEPRESSION; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 83155192034     PISSN: 09517367     EISSN: 14736578     Source Type: Journal    
DOI: 10.1097/YCO.0b013e32834dc15d     Document Type: Review

References (64)

1. Hegerl U, Schönknecht P. Subdiagnostic depression. Are there treatments with clinically relevant effects? [in German]. Nervenarzt 2009; 80:532-539.
2. Saß H, Wittchen H-U, Zaudig M, Houben I. Diagnostische Kriterien DSM-IVTR. Göttingen: Hogrefe; 2003.
3. Judd LL, Rapaport MH, Paulus MP, Brown JL. Subsyndromal symptomatic depression: a newmood disorder? J Clin Psychiatry 1994; 55 (Suppl.):18-28. (Pubitemid 24135964)
4. Rucci P, Gherardi S, Tansella M, et al. Subthreshold psychiatric disorders in primary care: prevalence and associated characteristics. J Affect Disord 2003; 76:171-181. (Pubitemid 37013369)
5. Veerman JL, Dowrick C, Ayuso-Mateos JL, et al. Population prevalence of depression and mean Beck Depression Inventory score. Br J Psychiatry 2009; 195:516-519.
6. Hegerl U, Allgaier A-K, Henkel V, Mergl R. Can effects of antidepressants in patients with mild depression be considered as clinically significant? J Affect Disord 2011. [Epub ahead of print]
7. Blazer DG, Kessler RC, Swartz MS. Epidemiology of recurrent major and minor depression with a seasonal pattern. The National Comorbidity Survey. Br J Psychiatry 1998; 172:164-167. (Pubitemid 28097716)
8. Kessler RC, Zhao S, Blazer DG, Swartz M. Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey. J Affect Disord 1997; 45:19-30. (Pubitemid 27357460)
9. Preisig M, Merikangas KR, Angst J. Clinical significance and comorbidity of subthreshold depression and anxiety in the community. Acta Psychiatr Scand 2001; 104:96-103. (Pubitemid 32656084)
10. Rapaport MH, Judd LL. Minor depressive disorder and subsyndromal depressive symptoms: functional impairment and response to treatment. J Affect Disord 1998; 48:227-232. (Pubitemid 28244225)
11. Cuijpers P, Smit F. Excess mortality in depression: a meta-analysis of ommunity studies. J Affect Disord 2002; 72:227-236. (Pubitemid 35351282)
12. Penninx BW, Geerlings SW, Deeg DJ, et al. Minor and major depression and the risk of death in older persons. Arch Gen Psychiatry 1999; 56:889-895. (Pubitemid 29480124)
13. Fekadu A, Alem A, Medhin G, et al. Utility of the concept of minor depressive disorder: evidence from a large rural community sample in a developing country setting. J Affect Disord 2007; 104:111-118. (Pubitemid 350052320)
14. Cuijpers P, Smit F, Oostenbrink J, et al. Economic costs of minor depression: a population-based study. Acta Psychiatr Scand 2007; 115:229-236.
15. Cuijpers P, Smit F. Subthreshold depression as a risk indicator for major depressive disorder: a systematic review of prospective studies. Acta Psychiatr Scand 2004; 109:325-331. (Pubitemid 38491278)
16. Hegerl U, Mergl R. The clinical significance of antidepressant treatment effects cannot be derived from placebo-verum response differences [Editorial]. J Psychopharmacol 2010; 24:445-448.
17. Mergl R, Schönknecht P, Allgaier A-K, et al. Effects of pharmaco- and psychotherapy in minor depressive disorders - is there a clinical significance? [in German] Nervenheilkunde (in press).
18. Barbui C, Cipriani A, Patel V, et al. Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. Br J Psychiatry 2011; 198:11-16.
19. Barrett JE, Williams JW Jr, Oxman TE, et al. Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years. J Fam Pract 2001; 50:405-412. (Pubitemid 32440814)
20. Burrows AB, Salzman C, Satlin A, et al. A randomized, placebo-controlled trial of paroxetine in nursing home residents with nonmajor depression. Depress Anxiety 2002; 15:102-110. (Pubitemid 34522470)
21. Davidson JR, Giller EL, Zisook S, Overall JE. An efficacy study of isocarboxazid and placebo in depression, and its relationship to depressive nosology. Arch Gen Psychiatry 1988; 45:120-127. (Pubitemid 18052842)
22. Frank E, Rucci P, Katon W, et al. Correlates of remission in primary care patients treated for minor depression. Gen Hosp Psychiatry 2002; 24:12-19. (Pubitemid 34113727)
23. Hollyman JA, Freeling P, Paykel ES, et al. Double-blind placebo-controlled trial of amitriptyline among depressed patients in general practice. J R Coll Gen Pract 1988; 38:393-397.
24. Judd LL, Rapaport MH, Yonkers KA, et al. Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder. Am J Psychiatry 2004; 161:1864-1871. (Pubitemid 39314681)
25. Oxman TE, Barrett JE, Sengupta A, et al. Status of minor depression or dysthymia in primary care following a randomized controlled treatment. Gen Hosp Psychiatry 2001; 23:301-310. (Pubitemid 33095094)
26. Paykel ES, Freeling P, Hollyman JA. Are tricyclic antidepressants useful for mild depression? A placebo controlled trial. Pharmacopsychiatry 1988; 21:15-18. (Pubitemid 18073875)
27. Paykel ES, Hollyman JA, Freeling P, Sedgwick P. Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebocontrolled trial. J Affect Disord 1988; 14:83-95. (Pubitemid 18016386)
28. Sullivan MD, Katon WJ, Russo JE, et al. Patient beliefs predict response to paroxetine among primary care patients with dysthymia and minor depression. J Am Board Fam Pract 2003; 16:22-31.
29. Williams JW Jr, Barrett J, Oxman T, et al. Treatment of dysthymia and minor depression in primary care: a randomized controlled trial in older adults. JAMA 2000; 284:1519-1526.
30. Rush AJ, Giles DE, Schlesser MA, et al. The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatr Res 1986; 18:65-87. (Pubitemid 16085767)
31. Rapaport MH, Nierenberg AA, Howland R, et al. The treatment of minor depression with St. John's Wort or citalopram: failure to show benefit over placebo. J Psychiatr Res 2011; 45:931-941.
32. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62.
33. Hegerl U, Hautzinger M, Mergl R, et al. Effects of pharmacotherapy and psychotherapy in depressed primary-care patients: a randomized, controlled trial including a patients' choice arm. Int J Neuropsychopharmacol 2010; 13:31-44.
34. Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 2010; 303:47-53.
35. Kirsch I, Deacon BJ, Huedo-Medina TB, et al. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 2008; 5:e45.
36. NICE. Depression: management of depression in primary and secondary care. Clinical practice guideline No. 23. London: National Institute for Clinical Excellence; 2004.
37. Pampallona S, Bollini P, Tibaldi G, et al. Patient adherence in the treatment of depression. Br J Psychiatry 2002; 180:104-109. (Pubitemid 34142778)
38. Demyttenaere K, Adelin A, Patrick M, et al. Six-month compliance with antidepressant medication in the treatment of major depressive disorder. Int Clin Psychopharmacol 2008; 23:36-42. (Pubitemid 350294868)
39. Sneed JR, Rutherford BR, Rindskopf D, et al. Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression. Am J Geriatr Psychiatry 2008; 16:65-73.
40. Sinyor M, Levitt AJ, Cheung AH, et al. Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses. J Clin Psychiatry 2010; 71:270-279.
41. Henkel V, Seemüller F, Obermeier M, et al. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression. J Affect Disord 2009; 115:439-449.
42. Papakostas GI, Perlis RH, Scalia MJ, et al. A meta-analysis of early sustained response rates between antidepressants and placebo for the treatment of major depressive disorder. J Clin Psychopharmacol 2006; 26:56-60. (Pubitemid 43167092)
43. Stassen HH, Angst J, Hell D, et al. Is there a common resilience mechanism underlying antidepressant drug response? Evidence from 2848 patients. J Clin Psychiatry 2007; 68:1195-1205. (Pubitemid 47395621)
44. Szegedi A, Müller MJ, Anghelescu I, et al. Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression. J Clin Psychiatry 2003; 64:413-420. (Pubitemid 36547285)
45. Tadiç A, Helmreich I, Mergl R, et al. Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression. J Affect Disord 2010; 120:86-93.
46. Taylor MJ, Freemantle N, Geddes JR, Bhagwagar Z. Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Arch Gen Psychiatry 2006; 63:1217-1223. (Pubitemid 44708080)
47. van Calker D, Zobel I, Dykierek P, et al. Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy. J Affect Disord 2009; 114:243-253.
48. Blier P, Keller MB, Pollack MH, et al. Preventing recurrent depression: longterm treatment for major depressive disorder. J Clin Psychiatry 2007; 68:e06.
49. Geddes J, Freemantle N, Mason J, et al. Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression. Cochrane Database Syst Rev 2006; 3:CD001851.
50. Kornstein SG. Maintenance therapy to prevent recurrence of depression: summary and implications of the PREVENT study. Expert Rev Neurother 2008; 8:737-742. (Pubitemid 351656824)
51. Reynolds CF 3rd, Dew MA, Pollock BG, et al. Maintenance treatment of major depression in old age. N Engl J Med 2006; 354:1130-1138.
52. Geddes JR, Carney SM, Davies C, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003; 361:653-661. (Pubitemid 36246547)
53. Judd LL, Akiskal HS, Maser JD, et al. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 1998; 55:694-700. (Pubitemid 28364385)
54. Fogel J, Eaton WW, Ford DE. Minor depression as a predictor of the first onset of major depressive disorder over a 15-year follow-up. Acta Psychiatr Scand 2006; 113:36-43. (Pubitemid 43339087)
55. Lyness JM, Heo M, Datto CJ, et al. Outcomes of minor and subsyndromal depression among elderly patients in primary care settings. Ann Intern Med 2006; 144:496-504. (Pubitemid 46780672)
56. Porter R, Frampton C, Joyce PR, Mulder RT. Randomized controlled trials in psychiatry. Part 1: methodology and critical evaluation. Aust N Z J Psychiatry 2003; 37:257-264. (Pubitemid 36833754)
57. Ventegodt S, Andersen NJ, Brom B, et al. Evidence-based medicine: four fundamental problems with the randomized clinical trial (RCT) used to document chemical medicine. Int J Adolesc Med Health 2009; 21:485-496.
58. Mosenifar Z. Population issues in clinical trials. Proc Am Thorac Soc 2007; 4:185-188.
59. Van Spall HG, Toren A, Kiss A, Fowler RA. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA 2007; 297:1233-1240. (Pubitemid 46465731)
60. DGPPN, BAä K, KBV. S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression - Langfassung. Berlin, Duä sseldorf: DGPPN, Aä ZQ, AWMF; 2009.
61. NICE. Depression: the treatment and management of depression in adults. National Clinical Practice Guideline 90. London: National Institute for Health and Clinical Excellence; 2009.
62. Cuijpers P, Smit F, Bohlmeijer E, et al. Efficacy of cognitive- behavioural therapy and other psychological treatments for adult depression: meta-analytic study of publication bias. Br J Psychiatry 2010; 196:173-178.
63. Cuijpers P, van Straten A, Bohlmeijer E, et al. The effects of psychotherapy for adult depression are overestimated: a meta-analysis of study quality and effect size. Psychol Med 2010; 40:211-223.
64. Hegerl U, Plattner A, Moä ller H-J. Should combined pharmaco- and psychotherapy be offered to depressed patients? A qualitative review of randomized clinical trials from the 1990s. Eur Arch Psychiatr Clin Neurosci 2004; 254:99-107. (Pubitemid 39304477)